Top Suppliers:I want be here

221246-34-0

221246-34-0 structure
221246-34-0 structure
  • Name: 17-TRIFLUOROMETHYLPHENYL TRINOR PROSTAGLANDIN F2ALPHA
  • Chemical Name: (1R,2S,3R)-3-ethyl-2-[(3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]pent-1-enyl]cyclopentan-1-ol
  • CAS Number: 221246-34-0
  • Molecular Formula: C24H31F3O5
  • Molecular Weight: 456.495
  • Create Date: 2016-10-29 00:10:00
  • Modify Date: 2024-01-09 13:42:28
  • 17-trifluoromethylphenyl trinor Prostaglandin F2α bears an aromatic ring, and acts very much like the free acid of travoprost.

Name (1R,2S,3R)-3-ethyl-2-[(3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]pent-1-enyl]cyclopentan-1-ol
Synonyms (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(1E,3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]-1-penten-1-yl}cyclopentyl]-5-heptenoic acid
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]-1-penten-1-yl]cyclopentyl]-, (5Z)-
(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3S)-3-hydroxy-5-[3-(trifluoromethyl)phenyl]pent-1-en-1-yl}cyclopentyl]hept-5-enoic acid
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-{(1E,3S)-3-hydroxy-5-[4-(trifluoromethyl)phenyl]-1-penten-1-yl}cyclopentyl]-5-heptenoic acid
5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-[4-(trifluoromethyl)phenyl]-1-penten-1-yl]cyclopentyl]-, (5Z)-
17-trifluoromethylphenyl trinor Prostaglandin F2alpha
Density 1.3±0.1 g/cm3
Boiling Point 600.0±50.0 °C at 760 mmHg
Molecular Formula C24H31F3O5
Molecular Weight 456.495
Flash Point 316.6±30.1 °C
Exact Mass 456.212372
PSA 97.99000
LogP 2.69
Vapour Pressure 0.0±1.8 mmHg at 25°C
Index of Refraction 1.575

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522

~%

221246-34-0 structure

221246-34-0

Literature: DeLong, Mitchell A.; Amburgey, Jack; Taylor, Cynthia; Wos, John A.; Soper, David L.; Wang, Yili; Hicks, Renee Bioorganic and Medicinal Chemistry Letters, 2000 , vol. 10, # 14 p. 1519 - 1522